September 20, 2025 11:00 ET | Source: C4 Therapeutics, Inc. Cemsidomide in Combination With Dexamethasone Achieved a 50% Overall Response…
NORWALK, Conn., Sept. 20, 2025 (GLOBE NEWSWIRE) -- Today, the Multiple Myeloma Research Foundation® (MMRF) announced that data generated from…
NEW YORK, Sept. 18, 2025 /PRNewswire/ -- The New York Stock Exchange will hold the 2nd annual NYSE International Day,…
Austin, Texas, Sept. 17, 2025 (GLOBE NEWSWIRE) -- The Global Citizen Hub has formally introduced The Ultimate European Scholarship Database,…
HONG KONG, Sept. 17, 2025 /PRNewswire/ -- UnionPay International (UPI), a global leader in payment solutions, announced the launch of its…
Biometrics leader DERMALOG outperforms global competitors in LivDet-Iris 2025, achieving 99.99 percent accuracy in detecting advanced contact lens fraud and…
NEW DELHI, Sept. 15, 2025 /PRNewswire/ -- PEI-Genesis, a global leader in custom-engineered connector and cable assembly solutions, is pleased…
DENVER, Sept. 12, 2025 /PRNewswire/ -- Demand AI Group Inc. ("Demand AI"), the fast-growing AI-driven B2B marketing and lead-generation company,…
SINGAPORE, Sept. 12, 2025 /PRNewswire/ -- Global consulting firm J.S. Held announces a collaboration between the International Valuation Standards Council (IVSC),…
BEIJING, Sept. 11, 2025 /PRNewswire/ -- The opening ceremony of the 16th China Yangtze River Three Gorges International Tourism Festival was…